---
figid: PMC5992473__gr9
figlink: /pmc/articles/PMC5992473/figure/fig9/
number: F9
caption: The Schematic Illustrates a Model of miR372 Promotes Liver Cancer Cell Growth
  by Upregulating erbB-2 through Enhancing YB-1 via Targeting for PTENmiR372 accelerates
  malignant progression of liver cancer cells in vitro and in vivo. Mechanistically,
  miR372 enhances expression of YB-1 and consequently promotes phosphorylation of
  YB-1 via HULC looping dependent on ERK1/2 and PTEN. Moreover, miR372 inhibits the
  degradation of β-catenin dependent on phosphorylation of YB-1 and then enhances
  the expression and activity PKM2 by β-catenin-LEF/TCF4 pathway. Furthermore, the
  loading of LEF/TCF4 on PKM2 promoter region is significantly increased in miR372-overexpressed
  liver cancer cells. Ultimately, miR372 promotes the expression of erbB-2 through
  PKM2-pH3T11-H3K9Ac pathway.
pmcid: PMC5992473
papertitle: miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2
  through Enhancement of YB-1.
reftext: Zhuojia Lin, et al. Mol Ther Nucleic Acids. 2018 Jun 1;11:494-507.
pmc_ranked_result_index: '50910'
pathway_score: 0.9223843
filename: gr9.jpg
figtitle: Schematic Illustrates a Model of miR372 Promotes Liver Cancer Cell Growth
  by Upregulating erbB-2 through Enhancing YB-1 via Targeting for PTENmiR372 accelerates
  malignant progression of liver cancer cells in vitro and in vivo
year: '2018'
organisms:
- Mus musculus
- Sesamum indicum
- Homo sapiens
- Bos taurus
- Oryctolagus cuniculus
ndex: 5cffd368-df0d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5992473__gr9.html
  '@type': Dataset
  description: The Schematic Illustrates a Model of miR372 Promotes Liver Cancer Cell
    Growth by Upregulating erbB-2 through Enhancing YB-1 via Targeting for PTENmiR372
    accelerates malignant progression of liver cancer cells in vitro and in vivo.
    Mechanistically, miR372 enhances expression of YB-1 and consequently promotes
    phosphorylation of YB-1 via HULC looping dependent on ERK1/2 and PTEN. Moreover,
    miR372 inhibits the degradation of β-catenin dependent on phosphorylation of YB-1
    and then enhances the expression and activity PKM2 by β-catenin-LEF/TCF4 pathway.
    Furthermore, the loading of LEF/TCF4 on PKM2 promoter region is significantly
    increased in miR372-overexpressed liver cancer cells. Ultimately, miR372 promotes
    the expression of erbB-2 through PKM2-pH3T11-H3K9Ac pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3L1
  - CTNNB1
  - CREB5
  - ERBB2
  - MAPK3
  - MAPK1
  - ATP6AP1
  - CREB3L3
  - CREB3
  - CREM
  - CDK2
  - CREB1
  - CCNE2
  - CCNE1
  - PTEN
  - CTCF
  - CREB3L2
  - ATF2
  - PKM
  - YBX1
  - TCF4
  - ATF1
  - CREB3L4
  - TCF4
  - glycosis
genes:
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: erbB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ORF
  symbol: ORF
  source: hgnc_alias_symbol
  hgnc_symbol: ATP6AP1
  entrez: '537'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CTCF
  symbol: CTCF
  source: hgnc_symbol
  hgnc_symbol: CTCF
  entrez: '10664'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: YB-1
  symbol: YB-1
  source: hgnc_alias_symbol
  hgnc_symbol: YBX1
  entrez: '4904'
- word: TCF4
  symbol: TCF4
  source: hgnc_symbol
  hgnc_symbol: TCF4
  entrez: '6925'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: Pa00,CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
chemicals:
- word: TCF4
  source: MESH
  identifier: C476718
diseases:
- word: glycosis
  source: ''
  identifier: ''
figid_alias: PMC5992473__F9
redirect_from: /figures/PMC5992473__F9
figtype: Figure
---
